STAT News
STAT+: China’s biotech boom is rewriting...
In today's Readout newsletter, how China's biotech boom is rewriting everything and how an NIH crackdown is disrupting global science collaboration.
Read original on statnews.com0
0Related
STAT News
STAT+: Amid focus on food, FDA leader briefs...
Infant formula safety, updating labels, defining ultraprocessed foods, and expanding inspections of processing plants are among the priorities.
statnews.com0
0STAT News
STAT+: In private meetings, White House works to...
The White House is working to build support for drug pricing legislation, part of an election year focus on affordability.
statnews.com0
0STAT News
The impact of NIH restrictions on foreign...
statnews.com0
0Liked this? Start your own feed.
Your own feed is waiting.
2 comments
This is a really insightful piece. The data backs up what I've been seeing in the industry.
Agreed. Would love to see a follow-up with more recent numbers.
I'm not sure the conclusion holds for smaller teams. Would be interesting to see this broken down by company size.